+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2015-07-27Number of Pages: 87

Cardiopulmonary Stress Testing Systems Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

The dramatic change in lifestyles marred by poor dietary intake, lack of exercise, and stressful schedules have all worked towards making the global population susceptible to obesity and related disorders. A growing consequence of this is seen in the rising number of cardiac patients, who, in turn, have increased the uptake of cardiopulmonary stress testing systems. These systems are used for evaluating the condition of the patient’s heart. According to the World Health Organization (WHO), coronary artery diseases account for 64% of overall cardiovascular deaths across the globe, which has become the primary cursor for increasing sales of cardiopulmonary stress testing systems. In a bid to help patients take well-calculated preventive measures, healthcare centers are adopting various types of cardiopulmonary stress testing systems to provide holistic health checkups. 

Transparency Market Research’s recently published report states that the opportunity in the global cardiopulmonary stress testing systems will be worth US$6.67 bn by 2023 as compared to US$3.30 bn in 2014. Between 2015 and 2023, the market is expected to rise at a CAGR of 8.20%. The global market will also receive a boost from growing healthcare infrastructure in the developing countries. The increasing disposable incomes, rising awareness amongst people about cardiovascular diseases and other related conditions, and the burgeoning health insurance industry are collectively expected to provide this market an impetus. 

Obesity Continues to Fuel North America Market

The North America cardiopulmonary stress testing systems market is expected to expand at a CAGR of 7.3% between 2015 and 2023. The growth in this region will be attributable to the high adoption rate of cardiac monitoring equipment such as cardiopulmonary exercise testing (CPET) systems, pulse oximeters, stress ECG, SPECT, and stress blood pressure monitors. A high incidence of cardiac disorders in the region due to rising cases of obesity are the prime reason for the remarkable growth of this regional market. 

The presence of leading equipment manufacturers in the North America cardiopulmonary stress testing systems market, high awareness amongst people, and enactment of laws such as Affordable Healthcare Act have further bolstered the demand for such equipment in the recent years. The market in North America has also benefited from supportive healthcare infrastructure and introduction of innovative products with ongoing research and development activities. 

Asia Pacific is anticipated to be the next big regional market in the overall cardiopulmonary stress testing systems market. The improving purchasing power of consumers, a huge population base, and growing number of patients being diagnosed with cardiovascular diseases will keep this region at the forefront of the global market in the near future. 

Demand for CPET Increases with Technological Advancements

Amongst the various types of products studied in the report, the cardiopulmonary exercise testing (CPET) systems are expected to see an upswing in demand. This segment includes portable CPET systems and desktop CPET systems. The critical role of this non-invasive test to ascertain pulmonary, neuropsychological, hematopoietic, cardiovascular, and skeletal muscle systems’ response to exercise has been propelling the growth of these systems. Technological advancements in this equipment to evaluate the functional parameters are anticipated to boost the market’s growth. The report states that the CPET systems segment will expand at a CAGR of 8.5% between 2015 and 2023. 

Some of the leading players operating in the global cardiopulmonary stress testing systems market are Spacelabs Healthcare, GE Healthcare, Philips Healthcare, and CareFusion Corporation. Analysts state that players must look at investing in developing regions as the countries will have higher healthcare budgets in the coming years. Furthermore, companies could also benefit from the rising medical tourism industry in the emerging economies that are willing to spend on acquiring new equipment and systems. 

 
Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Secondary Research
1.3.2 Primary Research
1.4 Assumptions
 
Chapter 2 Executive Summary
2.1 Market Snapshot: Global Cardiopulmonary Stress Testing Systems Market (2014 & 2023)
2.2 Global Cardiopulmonary Stress Testing Systems Market Revenue, by Type, 2014 (USD Million)
2.3 Comparative Analysis: Global Cardiopulmonary Stress Testing Systems Market Revenue, by Geography, 2014 & 2023 (Value %)
 
Chapter 3 Market Overview
3.1 Overview
3.2 Market Drivers
3.2.1 Increasing prevalence of coronary artery disease
3.2.2 Rise in global obesity rate along with aging population likely to trigger demand for CPST systems
3.2.2.1 Absolute number of coronary heart disease deaths by decade of age, 2010 – 2040
3.2.3 Penetration of new monitoring technology greatly enhances diagnosis rate
3.3 Market Restraints
3.3.1 Implementation of legal provisions (e.g. Affordable Care Act) that promote cost containment/cost cutting strategies
3.3.2 Slow growth in the number of SPECT MPI procedures
3.4 Opportunities
3.4.1 Presence of a huge potential market in most emerging nations globally
3.5 Event Impact Analysis
3.6 Number of Cardiac Stress Test Procedures Performed from MPI SPECT Test in U.S. and Europe
3.7 Porter’s Five Forces Analysis of the Global Cardiopulmonary Stress Testing Systems Market
3.7.1 Bargaining power of suppliers
3.7.2 Bargaining power of buyers
3.7.3 Threat of substitutes
3.7.4 Threat of new entrants
3.7.5 Competitive rivalry
3.8 Market Attractiveness Analysis: Global Cardiopulmonary Stress Testing Systems Market, by Geography
3.9 Competitive Landscape
3.9.1 Market Share Analysis: Global Cardiopulmonary Stress Testing Systems Market, 2014 (Value %)
3.10 Regulatory Framework
 
Chapter 4 Global Cardiopulmonary Stress Testing Systems Market, by Product Type
4.1 Introduction
4.1.1 Global Cardiopulmonary Stress Testing Systems Market Revenue, by Types, 2013 – 2023 (USD Million)
4.2 Average Pricing Analysis
4.3 Cardiopulmonary Exercise Testing (CPET) Systems
4.3.1 Global CPET Systems Market Revenue, by Type, 2013 – 2023 (USD Million)
4.3.2 Portable CPET Systems
4.3.3 Global Portable CPET Systems Market Revenue, 2013 – 2023 (USD Million)
4.3.4 Stationary CPET Systems
4.3.5 Global Stationary CPET Systems Market Revenue, 2013 – 2023 (USD Million)
4.4 Stress ECG
4.4.1 Global Stress ECG Market Revenue, 2013 – 2023 (USD Million)
4.5 Pulse Oximeters
4.5.1 Global Pulse Oximeters Market Revenue, 2013 – 2023 (USD Million)
4.6 Stress Blood Pressure Monitors
4.6.1 Global Stress Blood Pressure Monitors Market Revenue, 2013 – 2023 (USD Million)
4.7 Single-Photon Emission Computed Tomography (SPECT)
4.7.1 Global SPECT Market Revenue, 2013 – 2023 (USD Million)
 
Chapter 5 Global Cardiopulmonary Stress Testing Systems Market, by Geography
5.1 Overview
5.1.1 Global Cardiopulmonary Stress Testing Systems Market Revenue, by Geography, 2013 – 2023 (USD Million)
5.2 North America : U.S. and Canada
5.2.1 North America Cardiopulmonary Stress Testing Systems Market Revenue, by Country, 2013 – 2023 (USD Million)
5.3 Europe : Germany, U.K. and Rest of Europe
5.3.1 Europe Cardiopulmonary Stress Testing Systems Market Revenue, by Country, 2013 – 2023 (USD Million)
5.4 Asia-Pacific (APAC) : India, China and Rest of APAC
5.4.1 Asia-Pacific Cardiopulmonary Stress Testing Systems Market Revenue, by Country, 2013 – 2023 (USD Million)
5.5 Latin America (LATAM) : Brazil, Mexico and Rest of LATAM
5.5.1 LATAM Cardiopulmonary Stress Testing Systems Market Revenue, by Country, 2013 – 2023 (USD Million)
5.6 MENA : Saudi Arabia, UAE and Rest of MENA
5.6.1 MENA Cardiopulmonary Stress Testing Systems Market Revenue, by Country, 2013 – 2023 (USD Million)
5.7 Rest of the World (RoW)
5.7.1 RoW Cardiopulmonary Stress Testing Systems Market Revenue, 2013 – 2023 (USD Million)
 
Chapter 6 Recommendations
6.1 Investing in emerging markets in Asia Pacific, Latin America, and Africa
6.2 Focus on improved and technologically advanced cardiopulmonary stress testing systems
 
Chapter 7 Company Profiles
7.1 CareFusion Corporation
7.1.1 Company Overview
7.1.2 Financial Overview
7.1.3 Product Portfolio
7.1.4 Business Strategies
7.1.5 Recent Developments
7.2 COSMED
7.2.1 Company Overview
7.2.2 Financial Overview
7.2.3 Product Portfolio
7.2.4 Business Strategies
7.2.5 Recent Developments
7.3 GE Healthcare
7.3.1 Company Overview
7.3.2 Financial Overview
7.3.3 Product Portfolio
7.3.4 Business Strategies
7.3.5 Recent Developments
7.4 MGC Diagnostics Corporation
7.4.1 Company Overview
7.4.2 Financial Overview
7.4.3 Product Portfolio
7.4.4 Business Strategies
7.4.5 Recent Developments
7.5 Nihon Kohden Corporation
7.5.1 Company Overview
7.5.2 Financial Overview
7.5.3 Product Portfolio
7.5.4 Business Strategies 
7.5.5 Recent Developments
7.6 Philips Healthcare
7.6.1 Company Overview
7.6.2 Financial Overview
7.6.3 Product Portfolio
7.6.4 Business Strategies
7.6.5 Recent Developments
7.7 Schiller AG
7.7.1 Company Overview
7.7.2 Financial Overview
7.7.3 Product Portfolio
7.7.4 Business Strategies
7.7.5 Recent Developments
7.8 Spacelabs Healthcare
7.8.1 Company Overview
7.8.2 Financial Overview
7.8.3 Product Portfolio
7.8.4 Business Strategies
7.8.5 Recent Developments
7.9 SunTech Medical, Inc.
7.9.1 Company Overview
7.9.2 Financial Overview
7.9.3 Product Portfolio
7.9.4 Business Strategies
7.9.5 Recent Developments
7.10 Welch Allyn, Inc.
7.10.1 Company Overview
7.10.2 Financial Overview
7.10.3 Product Portfolio
7.10.4 Business Strategies
7.10.5 Recent Developments

List of Figures
 
FIG. 1 Cardiopulmonary Stress Testing Systems: Market Segmentation
FIG. 2 Global Cardiopulmonary Stress Testing Systems Market, by Type, 2014 (USD Million)
FIG. 3 Comparative Analysis: Global Cardiopulmonary Stress Testing Systems Revenue, by Geography, 2014 & 2023 (Value %)
FIG. 4 Absolute number of coronary heart disease deaths by decade of age, 2010 – 2040
FIG. 5 Porter’s Five Forces Analysis: Global Cardiopulmonary Stress Testing Systems Market
FIG. 6 Market Attractiveness Analysis: Global Cardiopulmonary Stress Testing Systems Market, by Geography (2014)
FIG. 7 Market Share Analysis, by Key Players: Global Cardiopulmonary Stress Testing Systems Market, 2014 (Value %)
FIG. 8 Global Portable CPET Systems Market Revenue, 2013 – 2023 (USD Million)
FIG. 9 Global Stationary CPET Systems  Market Revenue, 2013 – 2023 (USD Million)
FIG. 10 Global Stress ECG Market Revenue, 2013 – 2023 (USD Million)
FIG. 11 Global Pulse Oximeters Market Revenue, 2013 – 2023 (USD Million)
FIG. 12 Global Stress Blood Pressure Monitors Market Revenue, 2013 – 2023 (USD Million)
FIG. 13 Global SPECT Market Revenue, 2013 – 2023 (USD Million)
FIG. 14 RoW Cardiopulmonary Stress Testing Systems Market Revenue, 2013 – 2023 (USD Million)
FIG. 15 CareFusion Corporation: Annual Revenue, 2012 – 2014 (USD Million)
FIG. 16 GE Healthcare: Annual Revenue, 2012 – 2014 (USD Million)
FIG. 17 MGC Diagnostic Corporation: Annual Revenue, 2012 – 2014 (USD Million)
FIG. 18 Nihon Kohden Corporation: Annual Revenue, 2012 – 2014 (USD Million)
FIG. 19 Philips Healthcare: Annual Revenue, 2012 – 2014 (USD Million)
FIG. 20 Spacelabs Healthcare: Annual revenue, 2012 – 2014 (USD Million)
FIG. 30 Medtronic, Plc., Annual Revenue: 2012 - 2014 (USD Million)
FIG. 31 Smiths Medical: Annual Revenue, 2012 – 2014 (USD Million)
FIG. 32 St. Jude Medical, Inc.: Annual Revenue, 2012 – 2014 (USD Million)
FIG. 33 Terumo Corporation: Annual Revenue, 2012 – 2014 (USD Million)

List of Tables
 
TABLE 1 Market Snapshot: Global Cardiopulmonary Stress Testing Systems Market (2014 & 2023)
TABLE 2 Global Cardiopulmonary Stress Testing Systems Market Revenue, by Types, 2013 – 2023 (USD Million)
TABLE 3 Global CPET Systems Market Revenue, by Type, 2013 – 2023 (USD Million)
TABLE 4 Global Cardiopulmonary Stress Testing Systems Market Revenue, by Geography, 2013 – 2023 (USD Million)
TABLE 5 North America Cardiopulmonary Stress Testing Systems Market Revenue, by Country, 2013 – 2023 (USD Million)
TABLE 6 Europe Cardiopulmonary Stress Testing Systems Market Revenue, by Country, 2013 – 2023 (USD Million)
TABLE 7 Asia-Pacific Cardiopulmonary Stress Testing Systems Market Revenue, by Country, 2013 – 2023 (USD Million)
TABLE 8 LATAM Cardiopulmonary Stress Testing Systems Market Revenue, by Country, 2013 – 2023 (USD Million)
TABLE 9 MENA Cardiopulmonary Stress Testing Systems Market Revenue, by Country, 2013 – 2023 (USD Million)

Cardiopulmonary stress testing is performed to evaluate exercise capacity and predict outcome in patients diagnosed with heart failure. The cardiopulmonary stress testing systems market report studies the current and future prospects of the market globally. The report comprises an elaborate executive summary, which includes a market snapshot that provides overall information of various segments and sub-segments included in the study. This section also provides overall information and data analysis of the global cardiopulmonary stress testing systems market with respect to leading market segments based on type of product, and geography.
 
The market overview section of the report comprises qualitative analysis of the overall cardiopulmonary stress testing systems market, considering the factors determining the market dynamics such as drivers, restraints, and opportunities, along with Porter’s Five Forces Analysis and market attractiveness analysis. In addition, various analyses such as event impact analysis, regulatory framework, market attractiveness analysis by geography, and competitive landscape by key players have been provided. Event impact analysis includes the study of major events such as introduction of new technologies, mergers and acquisitions, and changes that significantly impacted the market. Regulatory framework includes the study of different regulatory norms and procedures that regulate the approval and commercialization of cardiopulmonary stress testing systems and techniques. The market attractiveness analysis is provided to explain the intensity of competition in the market in different geographies. The competitive scenario between different market players is evaluated through market share analysis in the competitive landscape section of the report. All these factors would help market players take strategic decisions in order to strengthen their positions and expand their shares in the global cardiopulmonary stress testing systems market.
 
The global cardiopulmonary stress testing systems market has been segmented on the basis of device type and geography. Based on device type, the cardiopulmonary stress testing systems market has been categorized into five key segments: cardiopulmonary exercise testing (CPET) systems, stress ECG, pulse oximeters, stress blood pressure monitors, and single-photon emission computed tomography (SPECT). Cardiopulmonary exercise testing (CPET) systems have been further categorized into two sub-segments: portable CPET systems and stationary CPET systems. Market revenue in terms of USD million for the period between 2013 and 2023 along with compound annual growth rate (CAGR %) from 2015 to 2023 are provided for all segments, considering 2014 as the base year.
 
Geographically, the cardiopulmonary stress testing systems market has been categorized into six regions: North America, Europe, Asia-Pacific, Latin America, the Middle East and North Africa, and Rest of the World (RoW). North America comprises the U.S. and Canada. Europe comprises Germany, the U.K., and Rest of Europe. Asia-Pacific comprises China, India, and Rest of Asia Pacific. Latin America comprises Brazil, Mexico, and Rest of Latin America. The Middle East and North Africa (MENA) comprises Saudi Arabia, the United Arab Emirates, and Rest of MENA. The recommendations section included in the report would assist existing players to expand their market share and new companies to establish their presence in the cardiopulmonary stress testing systems market. The report also profiles major players in the cardiopulmonary stress testing systems market on the basis of various attributes such as company overview, financial overview, business strategies, product portfolio, and recent developments. Major players profiled in this report include CareFusion Corporation, COSMED, GE Healthcare, MGC Diagnostics Corporation, Nihon Kohden Corporation, Philips Healthcare, Schiller AG, Spacelabs Healthcare, SunTech Medical, Inc., and Welch Allyn, Inc. 
 
The global Cardiopulmonary Stress Testing Systems market is segmented as follows:
 
Global Cardiopulmonary Stress Testing Systems Market, by Product Type
  • Cardiopulmonary Exercise Testing (CPET) Systems
    • Portable CPET Systems
    • Desktop CPET Systems
  • Stress ECG
  • Pulse Oximeters
  • Stress Blood Pressure Monitors
  • SPECT
Global Cardiopulmonary Stress Testing Systems Market, by Geography
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
  • Rest of Europe
    • Asia-Pacific
    • China
    • India
    • Rest of Asia Pacific
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East and North Africa
    • Saudi Arabia
    • UAE
    • Rest of MENA
  • Rest of the World (RoW)


 
 
Back To Top